Trials / Completed
CompletedNCT00146432
Immunoadsorption of LPS, C5a and IL-6 in Severe Sepsis and Septic Shock (ISASS-1)
Prospective, Controlled Pilot Trial: Treatment of Patients in Severe Sepsis and Septic Shock With Immunoadsorption of LPS, IL-6, C5a
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Charite University, Berlin, Germany · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to determine whether immunoadsorption of LPS, Il-6 and C5a reduces systemic hyperinflammation, improves immune function and improves organ function in patients with severe sepsis and septic shock
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Immunoadsorption of LPS, IL-6 and C5a |
Timeline
- First posted
- 2005-09-07
- Last updated
- 2009-08-25
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00146432. Inclusion in this directory is not an endorsement.